This inventor holds 17 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Vaccine Development. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, National Research Council of Canada, New York University. Active years: 2008-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Rockville, MD (US) (2008 - 2013)
- Bethesda, MD (US) (2013 - 2017)
Company Filing History:
16 out of 3,697 
4 out of 1,039 
2 out of 1,729 
Years Active: 2008-2017
Areas of Expertise:
Title: **Joanna Kubler-Kielb: Innovator in Monoclonal Antibody Research**
Introduction
Joanna Kubler-Kielb, based in Bethesda, MD, is a prominent inventor with a remarkable portfolio of 17 patents. Her pioneering work in the field of monoclonal antibodies has significantly contributed to the advancement of therapeutic and diagnostic methods, enhancing the landscape of biomedical research.
Latest Patents
Among her latest patents, Joanna focuses on monoclonal antibodies that specifically bind to poly-γ-D-glutamic acid (γDPGA) present on cellular surfaces. Her disclosures include chimeric and humanized forms of these monoclonal antibodies, alongside fragments and the nucleic acids encoding for them. Additionally, she has outlined pharmaceutical compositions incorporating these antibodies, and has developed methods for their prophylactic, therapeutic, and diagnostic applications.
Career Highlights
Joanna's career is marked by her impactful contributions to two prestigious entities: the United States of America, as represented by the Secretary of the Department of Health and Human Services, and the National Research Council of Canada. Her research has not only led to important scientific discoveries but has also paved the way for future innovations in antibody research.
Collaborations
Throughout her career, Joanna has collaborated with notable scientists such as Rachel Schneerson and John B. Robbins. These partnerships have facilitated the exchange of ideas and advanced her research, leveraging collective expertise in the field.
Conclusion
Joanna Kubler-Kielb stands out as a key inventor in the realm of monoclonal antibody research. Her extensive patent portfolio and collaborative efforts highlight her commitment to innovation and the development of advanced therapeutic strategies. Through her work, Joanna continues to inspire future generations of inventors in the biomedical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile